Skip to main content
. 2010 Sep 28;66(6):1159–1165. doi: 10.1007/s00280-010-1447-1

Table 3.

Dose-escalation scheme, dose-limiting toxicity, and response

Dose level of docetaxel Patients Cycles DLT Type Response
30 mg/m2 6 24 2 2 Febrile neutropenia 2 CR, 3 PR,1 PD
35 mg/m2 6 27 2 1 Febrile neutropenia 3 CR, 3 PR
1 Anemia
40 mg/m2 6 19 3 2 Febrile neutropenia 1 CR, 4 PR,1 SD
1 Neutropenia
Total 18 70 7 Response rate: 88.9%

DLT dose-limiting toxicity, CR complete response, PR partial response, SD stable disease, PD progressive disease